Psychedelics can help dissolve the individual ego, an outcome sought in many spiritual traditions.
This dissolution fosters the understanding that one is not an isolated entity but part of a larger system.
Read morePSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Psychedelics can help dissolve the individual ego, an outcome sought in many spiritual traditions.
This dissolution fosters the understanding that one is not an isolated entity but part of a larger system.
Read moreHere’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read moreThis article looks at whether psychedelics are safe enough for recreational use.
Read moreResearch suggests that the psychedelic drug MDMA, an empathogenic stimulant also known as Molly or ecstasy, can spark changes in the brain that induce a childlike state of neuroplasticity and help forge new neural connections.
(It could well be approved for PTSD by the U.S. Food and Drugs Administration in August after two advanced stage trials showed significant benefits.)
Researchers are also studying other psychedelics as well, like the powerful drug ibogaine.
Read moreIn the twin data researchers reviewed, mania was also strongly correlated with a genetic predisposition to schizophrenia and to bipolar I disorder.
In other words, those who experienced manic symptoms after psychedelic use may have been more genetically prone to mental illnesses.
Read moreHere’s an interview with researcher Albert Garcia-Romeu, where he discusses the potential of psilocybin to address issues associated with cognitive decline, and noteworthy preliminary observations from his research.
Read moreChronic pain could be treated by psychedelics in the future.
Keep reading for more information on clinical trial research on using psychedelics for chronic pain.
Read moreA study published recently in PLOS One suggests that therapy may, in fact, play an important role in psilocybin-assisted therapy for major depressive disorder.
In a study of 24 participants with MDD, those who reported stronger alliance, or “sense of collaboration between patient and client,” with their therapist were more likely to show improvements in their depression scores after two psilocybin dosing sessions.
Stronger ratings of therapeutic alliance during the study’s final preparation session were correlated with improved depression scores for 12 months after the study.
Read moreThis article looks at how personality traits can influence psychedelic experiences.
Read more